Hematology and Oncology
US veterans who were exposed to Agent Orange have an increased risk of myeloproliferative neoplasms.
The novel JAK1-sparing inhibitor pacritinib is effective at reducing spleen enlargement and disease burden in MF patients.
The safety and efficacy of luspatercept is favorable for treating anemia in patients with myelofibrosis.
Patients admitted for atrial fibrillation who have myeloproliferative neoplasms have an increased risk of bleeding.
Part one of a two-part discussion on early stage ER+/HER2- breast cancer.
Extending colorectal cancer screening to older populations using stool testing results in more life years gained.
Advertisement
Expert Interviews on Hematology/Oncology
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
